Severe Asthma Management
Severe asthma patients account for as much as 60% of all asthma healthcare costs, and proper management of severe disease is essential.
Tag: Breo Ellipta
Severe Asthma Management
Severe asthma patients account for as much as 60% of all asthma healthcare costs, and proper management of severe disease is essential.
Read More
COPD, Asthma, and Pharmacology
Several new pharmacological treatments for COPD and asthma have appeared on the respiratory market in the past year but what are the advantages these new generation pharmaceuticals?
Read MoreCOPD Treatment Breo Ellipta Now Available in US
BREO ELLIPTA, a once-daily inhaled ICS/LABA for chronic obstructive pulmonary disease (COPD), is now available to pharmacies throughout the U.S., according to GlaxoSmithKline and Theravance Inc.
Read More
Breo Ellipta Gets FDA Approval for COPD
GlaxoSmithKline and Theravance Inc’s Breo Ellipta, an inhaled long-term, once-daily treatment for airflow obstruction in COPD patients, has received FDA approval.
Read More